HAE News and Press, Haemonetics Corporation From 11/02/23

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

2023-11-02 06:14:09 ET More on Haemonetics Haemonetics Offers Relatively Rare Momentum In A Tough Medical Device Environment Haemonetics' Fiscal Q1 2024: Blood, Sweat, And Stellar Gains Haemonetics Corporation (HAE) Q1 2024 Earnings Call Transcript Haemonetic...

Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website PR Newswire Financial release accessible online BOSTON , Nov. 2, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial result...

Haemonetics Corporation (HAE) is expected to report $0.94 for Q2 2024

2023-11-01 13:47:25 ET More on Haemonetics Haemonetics Offers Relatively Rare Momentum In A Tough Medical Device Environment Haemonetics' Fiscal Q1 2024: Blood, Sweat, And Stellar Gains Haemonetics Corporation (HAE) Q1 2024 Earnings Call Transcript Haemonetic...

2023-10-26 08:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-10-13 16:37:00 ET Summary Haemonetics has outperformed the medical device sector, with shares up 7% on very strong revenue growth in plasma collection and good margin leverage. The recent acquisition of OpSens expands Haemonetics' Hospital product portfolio; a specialty guide...

2023-10-10 08:15:36 ET More on Haemonetics, Opsens, etc. Haemonetics' Fiscal Q1 2024: Blood, Sweat, And Stellar Gains Citi opens upside catalyst watch for Haemonetics ahead of earnings report Opsens reports Q3 results For further details see: Haemonetics ...

Haemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc. PR Newswire Expands Haemonetics' Hospital portfolio with innovative fiber optic sensor technology for interventional cardiology Significant commercial synergies with Haemonetics' exist...

OPSENS SIGNS DEFINITIVE AGREEMENT FOR ITS ACQUISITION BY HAEMONETICS Canada NewsWire All amounts in this press release are in Canadian dollars. QUÉBEC CITY, QC , Oct. 10, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX...